Overview
Ropivacaine Use in Interscalene Block; What is the Minimal Effective Analgesic Concentration (MEAC 90)
Status:
Not yet recruiting
Not yet recruiting
Trial end date:
2021-09-30
2021-09-30
Target enrollment:
0
0
Participant gender:
All
All
Summary
This study aim to calculate the minimal effective ropivacaine concentration required achieve successful analgesic interscalene block in 90% of patients (MEAC90)Phase:
Phase 4Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Healthpoint HospitalTreatments:
Ropivacaine
Criteria
Inclusion Criteria:- Patients, who are scheduled for shoulder arthroscopy
Exclusion Criteria:
- - <18 y,
- ASA physical class greater >III
- BMI >40 has any contraindication for medications or techniques used in the study